TARDBP and Alzheimer disease: A presentation by Julie Schneider at Tau 2022 explored recent efforts to introduce a change in nomenclature to the AD/AD and related dementias (ADRD) field, with the aim of addressing important phenotypic variability among older individuals with a progressive amnestic syndrome and autopsy evidence of transactive response DNA binding protein of 43 kD (TDP‐43) pathology with or without AD pathology.